Seven differently sulphated hyaluronic acid derivatives, having a general formula HyalSx where x can be 1, 2, 2.5, 3, 3.5, 3.8, 4, were synthetized. Coagulation tests i.e. whole blood clotting time and thrombin time were performed on these compounds and significant prolongations were observed from HyalS2.5 up to HyalS4. All that means the heparin like activity increases by increasing the sulphation degree of hyaluronic acid. The interaction of each of them with thrombin and FXa was studied in order to understand the mechanism of coagulation inactivation and the role of the sulphate position in the disaccharide unit to favour the protease inhibiting reaction. The bioactivity of HyalSx in terms of FXa and thrombin inactivation increases increasing with sulphation degree but the FXa inactivation seems to be mediated by ATIII, while the aspecific electrostatic interaction seems to play an important role in the inactivation of thrombin. Also the interaction with human serum albumin was studied by technique and no changes of protein conformation was observed, as occurs in the case of heparin.

Magnani, A., Albanese, A., Lamponi, S., Barbucci, R. (1996). Blood-interaction performance of differently sulphated hyaluronic acids. THROMBOSIS RESEARCH, 81(3), 383-395 [10.1016/0049-3848(96)00009-6].

Blood-interaction performance of differently sulphated hyaluronic acids

MAGNANI, AGNESE;ALBANESE, ANTONIETTA;LAMPONI, STEFANIA;BARBUCCI, ROLANDO
1996-01-01

Abstract

Seven differently sulphated hyaluronic acid derivatives, having a general formula HyalSx where x can be 1, 2, 2.5, 3, 3.5, 3.8, 4, were synthetized. Coagulation tests i.e. whole blood clotting time and thrombin time were performed on these compounds and significant prolongations were observed from HyalS2.5 up to HyalS4. All that means the heparin like activity increases by increasing the sulphation degree of hyaluronic acid. The interaction of each of them with thrombin and FXa was studied in order to understand the mechanism of coagulation inactivation and the role of the sulphate position in the disaccharide unit to favour the protease inhibiting reaction. The bioactivity of HyalSx in terms of FXa and thrombin inactivation increases increasing with sulphation degree but the FXa inactivation seems to be mediated by ATIII, while the aspecific electrostatic interaction seems to play an important role in the inactivation of thrombin. Also the interaction with human serum albumin was studied by technique and no changes of protein conformation was observed, as occurs in the case of heparin.
Magnani, A., Albanese, A., Lamponi, S., Barbucci, R. (1996). Blood-interaction performance of differently sulphated hyaluronic acids. THROMBOSIS RESEARCH, 81(3), 383-395 [10.1016/0049-3848(96)00009-6].
File in questo prodotto:
File Dimensione Formato  
thromb res 1996.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 971.89 kB
Formato Adobe PDF
971.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/42032
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo